CrushSCI.com
77.2Average days
66Median days
13Fastest days
176Longest days
7352025 publications

Paper Review Records

All Paper Review Records

15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

20 days

Temporal Dynamics of Clinical Benefit in DIGIT-HF: The Impact of Treatment Persistence

Authors
ALDAMA-LÓPEZ GUILLERMO; LÓPEZ-VÁZQUEZ DOMINGO; REBOLLAL-LEAL FERNANDOShow moreShow less
Affiliations
University Hospital of A Coruña, Spain; Institute for Biomedical Research of A Coruña (INIBIC), A Coruña, SpainShow moreShow less
Source PDF DOI Publisher page
176 days

Sotagliflozin, suPAR, and Cardiovascular Outcomes in Patients With Diabetes and Heart Failure: A SOLOIST-WHF Ancillary Study

Authors
ANIS ISMAIL; GRACE ERNE; ALEXI VASBINDER; CHRISTINA G. HUTTEN; BAHJAT Z. GHAZZAL; IAN PIZZO; KRISTEN MACHADO DIAZ; TONIMARIE CLAIRE CATALAN; THERESA FARHAT; BRENNA KNOTT; PENNELOPE KUNKLE; MICHAEL SZAREK; MICHAEL J. DAVIES; PHILIPPE GABRIEL STEG; BERTRAM PITT; DEEPAK L. BHATT; SALIM S. HAYEKShow moreShow less
Affiliations
University of Texas Medical Branch, Department of Internal Medicine, Galveston, TX, USA; University of Michigan, Department of Internal Medicine, Division of Cardiology, Ann Arbor, MI, USA; University of Washington, School of Nursing, Department of Biobehavioral Nursing and Health Informatics, Seattle, WA, USA; Rush Institute for Healthy Aging, Rush University Medical Center, Chicago, IL, USA; University of Massachusetts Chan Medical School, Department of Medicine, Worcester, MA, USA; School of Public Health, SUNY Downstate Health Sciences University, Brooklyn, NY, USA; University of Colorado School of Medicine, Aurora, CO, USA; CPC Clinical Research, Aurora, CO, USA; Lexicon Pharmaceuticals Inc., The Woodlands, TX, USA; Université Paris-Cité, Institut Universitaire de France, INSERM U-1148, FACT (French Alliance for Cardiovascular Trials) and AP-HP (Assistance Publique-Hôpitaux de Paris), Hopital Bichat Paris, Paris, France; Department of Internal Medicine (Emeritus), University of Michigan School of Medicine, Ann Arbor, MI, USA; Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, NY, USAShow moreShow less
Source PDF DOI Publisher page
148 days

Effect of Intravenous Iron Combined With Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2i) on Ventricular Function and Myocardial Iron Content in Patients With Heart Failure With Reduced Ejection Fraction—Rationale for the COMBINED-HF Study

Authors
MAURICIO BUTZKE; MILTON PACKER; LUÍS EDUARDO ROHDE; ANDREIA BIOLO; FERNANDO LUÍS SCOLARI; MURILO FOPPA; VÂNIA NAOMI HIRAKATA; LUÍS BECK-DA-SILVAShow moreShow less
Affiliations
Cardiology Division at Hospital de Clínicas de Porto Alegre, Porto Alegre RS, Brazil; Post-Graduate Program in Cardiology and Cardiovascular Science at the Medical School of the Universidade Federal do Rio Grande do Sul, Porto Alegre RS, Brazil; Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, TexasShow moreShow less
Source PDF DOI Publisher page
25 days

Incentivizing a Safety Net Cardiac Recovery Pathway via the Heart Transplant Allocation System

Authors
SNEHAL R. PATEL; JOSEF STEHLIK; SHELLEY HALL; JENNIFER COWGER; STAVROS G. DRAKOSShow moreShow less
Affiliations
Department of Cardiology, Northwell, Hofstra School of Medicine, New Hyde Park, New York; Division of Cardiovascular Medicine, Department of Internal Medicine University of Utah Health and School of Medicine Salt Lake City Utah; Baylor University Medical Center, Dallas, Texas; Division of Cardiology, Henry Ford Hospital, Detroit, MichiganShow moreShow less
Source PDF DOI Publisher page
21 days

“Readiness for Discharge” as a Novel Endpoint in Heart Failure Trials

Authors
MUHAMMAD SHAHZEB KHAN; AHMED MUSTAFA RASHID; SEAN P. COLLINS; MARK C PETRIE; JEFFREY TESTANI; JAVED BUTLERShow moreShow less
Affiliations
Baylor Scott and White Research Institute, Dallas, Texas; Baylor College of Medicine, Temple, Texas; Baylor Scott and White Health: Heart Hospital Plano, Plano, Texas; Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, Tennessee; Geriatric Research, Education and Clinical Center, VA Tennessee Valley Healthcare System, Nashville, Tennessee; School of Cardiovascular and Metabolic Health, University of Glasgow, British Heart Foundation Glasgow Cardiovascular Research Centre, Glasgow, United Kingdom; Section of Cardiovascular Medicine, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut; Department of Medicine, University of Mississippi Medical Center, Jackson, MississippiShow moreShow less
Source PDF DOI Publisher page
66 days

Circulating Proteomic Profiles in Ambulatory Patients With Advanced Stage C2D Heart Failure: Insights From the Registry Evaluation of Vital Information for VADs in Ambulatory Life (REVIVAL) Registry

Authors
DOUGLAS L. MANN; JULIO A. CHIRINOS; JINSHENG YU; WEI YANG; DENNIS M. MCNAMARA; BLAIR RICHARDS; WENDY C. TADDEI-PETERS; NEAL JEFFRIES; GARRICK C. STEWART; CHENAO QIAN; THOMAS P. CAPPOLA; KEITH D. AARONSONShow moreShow less
Affiliations
Washington University School of Medicine, St. Louis, Missouri; Division of Cardiovascular Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania; University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania; University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania; University of Michigan, Ann Arbor, Michigan; National Heart Lung and Blood Institute, Bethesda, Maryland; Brigham and Women’s Hospital, Boston, MassachusettsShow moreShow less
Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review62 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at [email protected]

Enter your email address so we can reply. Your details will remain private.